Karen Brann
Family · Chicago Ridge, ILNPI 1043676448
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (46.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 54 manufacturers reported payments, led by Johnson & Johnson at 30.5% of the total. 2025 is the largest year on record at $26,769, more than ten times the $448 reported in 2021. Among family clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 533 payments — averaging $80.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$13K
- Janssen Scientific Affairs, LLC$7K
- Bayer$6K
- Accord Healthcare, Inc.$2K
- Teleflex LLC$2K
- AbbVie$1K
- plus $11K from 48 others
What the payments were for
- Consulting fees$19,75646%
- Speaking & faculty fees$1,7024%
- Travel & lodging$2,8637%
- Food & beverage$17,78642%
- Education$5531%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$42,660 in reported general payments places this provider in the 95th percentile of 4,941 family providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ErleadaApalutamide | 11 | $112,105 |
| GemtesaVibegron | 89 | $54,923 |
| MyrbetriqMirabegron | 81 | $46,404 |
| Tamsulosin Hcl | 340 | $6,356 |
| Solifenacin Succinate | 131 | $4,323 |
| Testosterone | 31 | $3,865 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 120 | $1,352 |
| Finasteride | 65 | $1,115 |
| Oxybutynin Chloride ErOxybutynin Chloride | 52 | $1,097 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 51 | $761 |
| Testosterone Cypionate | 19 | $687 |
| Estradiol | 12 | $668 |
| Sildenafil Citrate | 39 | $658 |
| Trospium Chloride | 12 | $545 |
| Tolterodine Tartrate ErTolterodine Tartrate | 11 | $423 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonErleada | $13,004 | $112,10511 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $978 | $54,92389 claims |
| Astellas Pharma US IncMyrbetriq | $1,106 | $46,40481 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,941 family providers in Illinois.
Other family in Chicago Ridge
- Ruth CarricoChicago$578K
- Aleksandra BielawiecBarrington$373K
- Erin SieberNaperville$334K
- Jamie BroganChicago$282K
- Ashley NoethGlen Carbon$271K
- Marita KametasChicago$259K
- Shammona ClarkChicago$247K
- Amanda McKeeMount Vernon$242K
- Amy BrownellElk Grove Village$202K
- Brittony CroasdellChicago$192K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.